Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference49 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;Ca - Cancer J. Clin.,2021
2. Molecular alterations in triple-negative breast cancer—the road to new treatment strategies;Denkert;Lancet,2017
3. Pattern of metastatic spread in triple-negative breast cancer;Dent;Breast Cancer Res. Treat.,2009
4. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease;Bianchini;Nat. Rev. Clin. Oncol.,2016
5. Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review;Li;Breast Cancer Res.,2019
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiovascular disease and thrombosis: Intersections with the immune system, inflammation, and the coagulation system;Annales Pharmaceutiques Françaises;2024-08
2. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer;Frontiers in Immunology;2024-04-19
3. Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements;International Journal of Molecular Sciences;2024-02-03
4. Chitosan-functionalized bioplatforms and hydrogels in breast cancer: immunotherapy, phototherapy and clinical perspectives;Drug Discovery Today;2024-01
5. Cancer-associated thrombosis: What about microRNAs targeting the tissue factor coagulation pathway?;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3